TRASTUZUMAB PACKAGE INSERT NO FURTHER A MYSTERY

Rare situations of nephrotic syndrome have been documented in people on trastuzumab therapy, with the best incidence in individuals with metastatic gastric cancer.When it comes to molecular networking, they showed that Src is the central mediator of all resistant pathways. All those capabilities allow Src a promising “international” therapeutic